Copper Intrauterine Device

  • Elizabeth H. McNany


The Intrauterine Device (IUD) is the most commonly used form of reversible contraception throughout the world [1], and in some countries it accounts for 40% of the contraception used by women [2]. In the United States (US), current use is 0.8% of the contraceptive population [3]. Prior to issues with infection and infertility with the Dalkon Shield in the 1970s, use in the US approached 10%. The newer IUDs are safe and effective forms of birth control when used in appropriate patients. Not only effective in preventing pregnancy with a failure rate of 0.42%, but if used for at least 5 years, it is one of the least expensive forms of birth control [4]. There are two IUDs currently in use in the US, the copper T 380A (in place for up to 10 years) and the levonorgestrel intrauterine system (in place for up to 5 years).


Ectopic Pregnancy Pelvic Inflammatory Disease Uterine Fibroid Oral Contraceptive Pill Uterine Perforation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Anonymous. IUDs: an update. Popul Rep B 1995;6:1–35.Google Scholar
  2. 2.
    Mauldin WP, Segal SJ. IUD use throughout the world: past, present and future. In Bardin CW, Mishell DR Jr (eds) Proceedings from the Fourth International Conference on IUDs. Boston, MA: Butterworth-Heinemann, 1994, pp 1–10.Google Scholar
  3. 3.
    Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States: 1982–1995. Fam Plann Perspect 1998;30:4–10, 46.PubMedCrossRefGoogle Scholar
  4. 4.
    Trussell J, Leveque JA, Koenig JD, London R, Borden S, Henneberry J, LaGuardia KD, Stewart F, Wilson TG, Wysocki S. The economic value of contraception: a comparison of 15 methods. Am J Public Health 1995;85(4):494–503.PubMedCrossRefGoogle Scholar
  5. 5.
    Canavan TP. Appropriate use of the intrauterine device. Am Fam Physician 1998;58(9):2077–2084, 2087–2088.PubMedGoogle Scholar
  6. 6.
    Xiong X, Buekens P, Wollast E. IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies. Contraception 1995;52:23–34.PubMedCrossRefGoogle Scholar
  7. 7.
    World Health Organization. Medical eligibility criteria for contraceptive use, 3rd edn. Geneva: WHO, 2004.Google Scholar
  8. 8.
    ACOG Practice Bulletin, Intrauterine Device, Number 59, January 2005.Google Scholar
  9. 9.
    Paragard package insert, FEI Products LLC, last revision September 2005.Google Scholar
  10. 10.
    White MK, Ory HW, Rooks JB, Rochat RW. Intrauterine device termination rates and the menstrual cycle day of insertion. Obstet Gynecol 1980;55:220–224.PubMedGoogle Scholar
  11. 11.
    Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992;339:785–788.PubMedCrossRefGoogle Scholar
  12. 12.
    Grimes DA, Schulz FK. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 1999, Issue 3. Art. No.: CD001327. DOI:  10.1002/14651858.CD001327.
  13. 13.
    Johnson BA. Insertion and removal of intrauterine devices. Am Fam Physician 2005;71(1): 95–102.PubMedGoogle Scholar

Additional Resources Website

  1. Supplier: Duramed Pharmaceuticals:

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Medical EducationSt. Joseph’s Family Medicine ResidencySyracuseUSA

Personalised recommendations